← Eichor
Study identifier: NCT05387031 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

Condition: Crohn Disease · Stricture; Bowel · Intestinal Stricture  ·  Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

PhaseN/A
Planned participants239
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This study intends to select patients with confirmed moderate-to-severe Crohn's disease (CD) and obstructive symptoms of intestinal stenosis, who have clear evidence of lumen stenosis caused by the disease itself through radiography or endoscopy. After the informed consent of the patients, comprehensive drug therapy with ustekinumab as the mainstay was performed. The basic information and medical history of the patients were collected, and the treatment process of the patients was followed up and recorded, and the drug regimen was adjusted according to the physician's experience and judgment. At different follow-up time points, blood, feces, tissue and other specimens of patients were collected according to the situation, and gastrointestinal endoscopy, imaging examination, laboratory index examination, self-assessment of subjects' symptoms, and nutritional risk screening were performed on the patients. This study evaluated the CD disease activity, obstructive symptoms, and radiographic or endoscopic remission in patients at different follow-up time points, and comprehensively evaluated the efficacy of ustekinumab in relieving stenotic CD and its related factors.

This description comes directly from the study's public registry record.

Talk to the study team

Yan Chen, MD.  ·  +86-571-87783777  ·  chenyan72_72@zju.edu.cn

Jingwen Liu, MD.  ·  +86-571-87767061  ·  jingwen@zju.edu.cn

Always discuss trial participation with your own doctor first.

Locations (8)

Department of Gastroenterology, Seventh Medical Center of PLA Army General HospitalBeijing, Beijing Municipality, ChinaRecruiting
Department of Gastroenterology, Chongqing Renji Hospital, University of Chinese Academy of SciencesChongqing, Chongqing Municipality, ChinaRecruiting
Department of Gastroenterology, Sixth Affiliated Hospital, Sun Yat-Sen UniversityGuangzhou, Guangdong, ChinaRecruiting
Department of Gastroenterology, Huai'an First People's HospitalHuai'an, Jiangsu, ChinaRecruiting
Department of Gastroenterology, Second Affiliated Hospital of Soochow UniversitySuzhou, Jiangsu, ChinaRecruiting
Department of Gastroenterology, Affiliated Hospital of Yangzhou UniversityYangzhou, Jiangsu, ChinaRecruiting
Center of Inflammatory Bowel Disease, Department of Gastroenterology, the Second Affiliated Hospital, Zhejiang University School of MedicineHangzhou, Zhejiang, ChinaRecruiting
Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical UniversityHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05387031